138 related articles for article (PubMed ID: 36238987)
21. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
22. Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer.
Simmons D; Blank SV; ElNaggar AC; Chastek B; Bunner SH; McLaurin K
Adv Ther; 2022 Jun; 39(6):2544-2561. PubMed ID: 35362863
[TBL] [Abstract][Full Text] [Related]
23. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
[TBL] [Abstract][Full Text] [Related]
24. Risk of contralateral ovarian cancer in patients undergoing conservative surgery for ovarian cancer.
Guo D; Wang Y; Wang S; Hu J; Chen X; Qu Z; Sui C; He G; Wang C; Liu X
Eur J Surg Oncol; 2022 Sep; 48(9):2053-2060. PubMed ID: 35450756
[TBL] [Abstract][Full Text] [Related]
25. [State of health of populations residing in geothermal areas of Tuscany].
Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
[TBL] [Abstract][Full Text] [Related]
26. Declining trends of epithelial ovarian cancer in California.
Morris CR; Rodriguez AO; Epstein J; Cress RD
Gynecol Oncol; 2008 Jan; 108(1):207-13. PubMed ID: 18028989
[TBL] [Abstract][Full Text] [Related]
27. Impact of geography and travel distance on outcomes in epithelial ovarian cancer: a national cancer database analysis.
Daruvala A; Lucas FL; Sammon J; Darus C; Bradford L
Int J Gynecol Cancer; 2021 Feb; 31(2):209-214. PubMed ID: 33214215
[TBL] [Abstract][Full Text] [Related]
28. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
Kelemen LE; Bandera EV; Terry KL; Rossing MA; Brinton LA; Doherty JA; Ness RB; Kjaer SK; Chang-Claude J; Köbel M; Lurie G; Thompson PJ; Carney ME; Moysich K; Edwards R; Bunker C; Jensen A; Høgdall E; Cramer DW; Vitonis AF; Olson SH; King M; Chandran U; Lissowska J; Garcia-Closas M; Yang H; Webb PM; Schildkraut JM; Goodman MT; Risch HA; ;
BMC Cancer; 2013 Jan; 13():28. PubMed ID: 23339562
[TBL] [Abstract][Full Text] [Related]
29. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
[TBL] [Abstract][Full Text] [Related]
30. Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act.
Sutaria T; Sparks AD; Rao YJ; Lopez-Acevedo M; Long B
Gynecol Oncol; 2020 Aug; 158(2):424-430. PubMed ID: 32534810
[TBL] [Abstract][Full Text] [Related]
31. Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data.
Adambekov S; Lopa S; Edwards RP; Lemon L; Wang S; Taylor SE; Orr B; Linkov F
Cancer Med; 2020 Oct; 9(20):7388-7397. PubMed ID: 32813321
[TBL] [Abstract][Full Text] [Related]
32. Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
Moss HA; Havrilesky LJ; Chino J
Gynecol Oncol; 2017 Sep; 146(3):457-464. PubMed ID: 28641821
[TBL] [Abstract][Full Text] [Related]
33. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
[TBL] [Abstract][Full Text] [Related]
34. The Patient Protection and Affordable Care Act dependent coverage expansion: Disparities in impact among young adult oncology patients.
Alvarez EM; Keegan TH; Johnston EE; Haile R; Sanders L; Wise PH; Saynina O; Chamberlain LJ
Cancer; 2018 Jan; 124(1):110-117. PubMed ID: 28940423
[TBL] [Abstract][Full Text] [Related]
35. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
36. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
Sakhuja S; Yun H; Pisu M; Akinyemiju T
J Ovarian Res; 2017 Aug; 10(1):57. PubMed ID: 28830564
[TBL] [Abstract][Full Text] [Related]
37. Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients.
Bairi KE; Trapani D; Page CL; Saad A; Jarroudi OA; Afqir S
Cancer Treat Res Commun; 2022; 33():100625. PubMed ID: 36057142
[TBL] [Abstract][Full Text] [Related]
38. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
39. The Affordable Care Act and Changes in Women's Health Insurance Coverage Before, During, and After Pregnancy in California.
Marchi KS; Dove MS; Heck KE; Fan C
Public Health Rep; 2021; 136(1):70-78. PubMed ID: 33108960
[TBL] [Abstract][Full Text] [Related]
40. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
